Finance

Lists
Why is 009420 up ၂.၇၃%?
Dive Deeper
009420:KRX
Hanall Biopharma Co Ltd
၄၃,၃၀၀.၀၀ ₩
+၂.၇၃%
(+၁,၁၅၀.၀၀) 1D
အောက် ၁၉, GMT+၉ ၁၅:၃၀:၂၄  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 009420...
Open
၄၁,၃၀၀ ₩
High
၄၃,၃၀၀ ₩
Low
၄၁,၀၅၀ ₩
Mkt. cap
ဋေ ၂.၂၆ သိန်း
Avg. vol.
၂.၄၂ သိန်း
Volume
၁.၅၉ သိန်း
52-wk high
၇၃,၀၀၀ ₩
52-wk low
၃၂,၆၀၀ ₩
EPS
-၄၉၀ ₩
Shares outstanding
၅.၂၂ ကုဋေ
No. of employees
၂၈၇
Open
၄၁,၃၀၀ ₩
High
၄၃,၃၀၀ ₩
Low
၄၁,၀၅၀ ₩
Mkt. cap
ဋေ ၂.၂၆ သိန်း
Avg. vol.
၂.၄၂ သိန်း
Volume
၁.၅၉ သိန်း
52-wk high
၇၃,၀၀၀ ₩
52-wk low
၃၂,၆၀၀ ₩
EPS
-၄၉၀ ₩
Shares outstanding
၅.၂၂ ကုဋေ
No. of employees
၂၈၇
News stories
From web sources and news partners
GlobeNewswire
GlobeNewswire
·
ပြီးခဲ့သည့် ၃၇ မိနစ်
Belite Bio Announces Uplisting to the Nasdaq Global Select Market
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၂၂ မိနစ်
Nasdaq gives LexinFintech (Nasdaq: LX) 180 days to regain bid-price compliance.
About Hanall Biopharma Co Ltd
CEOYoon Jae-chun | Seung Kook Park
Employees၂၈၇
Founded၁၉၇၃
Headquartersဆိုးလ်မြို့, Gangnam District, တောင်ကိုရီးယား
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၄.၀၈ ထ
ဋေ ၃.၇၅ ထ
ဋေ ၄.၀၀ ထ
ဋေ ၄.၄၃ ထ
Cost of goods sold
ဋေ ၁.၉၈ ထ
ဋေ ၁.၈၉ ထ
ဋေ ၁.၈၇ ထ
ဋေ ၁.၉၅ ထ
Cost of revenue
ဋေ ၁.၉၈ ထ
ဋေ ၁.၈၉ ထ
ဋေ ၁.၈၇ ထ
ဋေ ၁.၉၅ ထ
Research and development expenses
၄၇၆.၇၅ ဋေ
၃၅၇.၅၄ ဋေ
၃၅၁.၆၆ ဋေ
၃၇၂.၃၅ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၁.၅၆ ထ
ဋေ ၁.၆၈ ထ
ဋေ ၁.၆၆ ထ
ဋေ ၁.၅၂ ထ
Operating expense
ဋေ ၂.၀၇ ထ
ဋေ ၂.၁၄ ထ
ဋေ ၂.၀၅ ထ
ဋေ ၁.၉၃ ထ
Total operating expenses
ဋေ ၄.၀၅ ထ
ဋေ ၄.၀၃ ထ
ဋေ ၃.၉၂ ထ
ဋေ ၃.၈၈ ထ
Operating income
၃၄.၈၉ ကုဋေ
-၂၇၁.၁၆ ဋေ
၈၃.၈၇ ကုဋေ
၅၄၄.၇၇ ဋေ
Other non operating income
၆.၆၁ ကုဋေ
၉.၁၂ ကုဋေ
၅၆.၆၂ ကုဋေ
-ဋေ ၁.၀၉ ထ
EBT including unusual items
၃၄.၂၇ ကုဋေ
-၇၁၆.၁၆ ဋေ
၅၇.၀၂ ကုဋေ
-ဋေ ၂.၁၅ ထ
EBT excluding unusual items
၃၂.၄၂ ကုဋေ
-၂၇၄.၄၀ ဋေ
၅၇.၀၂ ကုဋေ
-၅၈၄.၅၅ ဋေ
Income tax expense
၄.၃၈ ကုဋေ
-၉၁.၂၂ ကုဋေ
၂၉.၅၂ ကုဋေ
-၂၂၇.၁၅ ဋေ
Effective tax rate
၁၂.၇၇%
၁၂.၇၄%
၅၁.၇၇%
၁၀.၅၇%
Other operating expenses
၁၇.၀၆ ကုဋေ
၁၅.၉၈ ကုဋေ
၁၇.၈၄ ကုဋေ
၁၆.၀၈ ကုဋေ
Net income
၂၉.၉၀ ကုဋေ
-၆၂၄.၉၄ ဋေ
၂၇.၅၀ ကုဋေ
-ဋေ ၁.၉၂ ထ
Net profit margin
၀.၇၃%
-၁၆.၆၄%
၀.၆၉%
-၄၃.၄၃%
Earnings per share
-
-
-
-
Interest and investment income
၆.၂၆ ကုဋေ
၅.၂၄ ကုဋေ
၁၃.၈၀ ကုဋေ
၂၀.၄၆ ကုဋေ
Interest expense
-၂.၀၂ ကုဋေ
-၈.၀၀ ကုဋေ
-၃၇.၂၇ ကုဋေ
-၄၁.၈၀ ကုဋေ
Net interest expenses
၄.၂၅ ကုဋေ
-၂.၇၆ ကုဋေ
-၂၃.၄၇ ကုဋေ
-၂၁.၃၄ ကုဋေ
Depreciation and amortization charges
၁၃.၆၉ ကုဋေ
၁၂.၉၆ ကုဋေ
၁၂.၉၁ ကုဋေ
၁၂.၅၃ ကုဋေ
EBITDA
၁၂၄.၈၉ ဋေ
-၁၈၂.၀၇ ဋေ
၁၆၇.၁၆ ဋေ
၆၁၈.၂၀ ဋေ
Gain or loss from assets sale
-၁.၈၅ ကုဋေ
-၄.၈၄ သန်း
-
၃၁.၉၁ ကုဋေ
AI content may include mistakes. Learn more
Google အက်ပ်များ